SCHEMBL29535262

SCHEMBL29535262

N[C@H]1C(O)O[C@H](CO)[C@@H](OS(=O)(=O)O)[C@@H]1OS(=O)(=O)O

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BLM P54132 1/20 0.35
RECQL P46063 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
MAPT P10636 1/20 0.34
FGF1 P05230 1/20 0.34
FGF2 P09038 1/20 0.34
LGALS3 P17931 1/20 0.33
GAA P10253 1/20 0.33
LMNA P02545 1/20 0.32
CA2 P00918 7/20 0.32
CA12 O43570 6/20 0.32
CA9 Q16790 6/20 0.32
CA1 P00915 5/20 0.32
CXCL10 P02778 1/20 0.32
CXCL8 P10145 1/20 0.32
CCL2 P13500 1/20 0.32
CCL5 P13501 1/20 0.32
CXCL12 P48061 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29535395 1.00 BLM (0.35) BLMRECQLTDP1MAPTFGF1
SCHEMBL21753793 0.89 BLM (0.37) BLMRECQLTDP1MAPTFGF1
SCHEMBL5523032 0.89 MAPT (0.39) BLMRECQLTDP1MAPTFGF1
SCHEMBL29535705 0.89 BLM (0.37) BLMRECQLTDP1MAPTFGF1
SCHEMBL19667936 0.89 MAPT (0.39) BLMRECQLTDP1MAPTFGF1
SCHEMBL29535305 0.89 MAPT (0.39) BLMRECQLTDP1MAPTFGF1
SCHEMBL1923003 0.88 FGF1 (0.36) BLMRECQLTDP1MAPTFGF1
SCHEMBL2186684 0.81 LGALS3 (0.38) BLMFGF1LGALS3CA2CA12
SCHEMBL3914085 0.81 LGALS3 (0.38) BLMFGF1LGALS3CA2CA12
SCHEMBL28201089 0.81 LGALS3 (0.38) BLMFGF1LGALS3CA2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240366853-A1 METHOD FOR MODULATING ENDOTHELIAL GLYCOCALYX STRUCTURE EXTHERA MEDICAL CORPORATION (US) 2024-11-07 US disclosed
US-12090261-B2 Method for modulating endothelial glycocalyx structure EXTHERA MEDICAL CORPORATION (US) 2024-09-17 US disclosed
EP-3969014-A1 METHOD FOR MODULATING ENDOTHELIAL GLYCOCALYX STRUCTURE ExThera Medical Corporation (US) 2022-03-23 EP disclosed